Intended use
Test for the quantitative determination of creatinine in
blood, serum, plasma or urine with Reflotron®.
Clinical aspects
Creatinine is produced from creatine and phosphocreatine during muscle metabolism.
In normal kidney function it is eliminated by glomerular filtration. Determination of creatinine
is used for the diagnosis and monitoring of acute and chronic kidney disorders
and for monitoring dialysis.
Available in a tube of 30 test/strips.
| Μονάδα Πώλησης | |
|---|---|
| SECTION | |
| COMPANY | |
| Αναλυτής |
Related products
DRY CHEMISTRY
Intended use: Test for the quantitative determination of the total activity of α?amylase (EC 3.2.1.1) in blood, serum or [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of urea in blood, serum or plasma with Reflotron. Clinical aspects [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of triglycerides in blood, serum or plasma with Reflotron®. Clinical aspects [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of GPT (ALT; ALAT; EC 2.6.1.2) in blood, serum or plasma [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of potassium in heparinized plasma or serum with Reflotron. Clinical aspects [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of cholesterol in blood, serum or plasma with Reflotron systems. Summary [...]
